The Link Between Nephrogenic Systemic Fibrosis and Gadolinium
Are you aware of the dangers associated with Gadolinium MRI Contrast Dye?
Worldwide, there have been over 215 reports linking gadolinium to a rare but
serious skin and joint disease.
People with kidney disease often have a
narrowing of the blood vessels due to their medical condition. Gadolinium is a
kind of intravenous dye given to patients during magnetic resonance imagings
(MRIs) to help radiologists better visualize their blood vessels.
Now, however, a rare disease, called Nephrogenic Systemic Fibrosis or
Nephrogenic Fibrosing Dermopathy (NSF/NFD), has been found to occur in patients
with moderate to severe kidney disease after they have had an MRI or magnetic
resonance angiography (MRA) scan with dye that contains gadolinium.
If
you have developed Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing
Dermopathy following an MRI/MRA, you deserve the guidance of a lawyer experienced in such cases. Please
complete the form below for a free legal evaluation.
see also:
Research Center
Read the Serious Health Risks Related to Gadolinium MRI Contrast DyeFDA Warning: Gadolinium MRI can lead to Nephrogenic Systemic Fibrosis
Complimentary Legal Review
Were you harmed by Gadolinium Dye? Free Lawyer Review of your caseComplete this form for a free case review by a Gadolinium Lawyer
Avandia
Get Vital News about Avandia, the Diabetes Drug With Heart Attack RiskStudy: Avandia Increases Risk of Heart Attacks in Diabetes Patients


